Navigation Links
Irvine Scientific and Selexis to Announce Results of Successful Collaboration

GENEVA, and SANTA ANA, Calif., Oct. 12 /PRNewswire/ -- Selexis SA ("Selexis") and Irvine Scientific Inc. ("Irvine") announced today plans to jointly present results of a recent collaborative effort combining the Selexis SURE Cell Line Development Programs(TM) and the Irvine IS CHO Culture System, demonstrating the rapid production of gram quantities of monoclonal antibodies from stable CHO production cell lines. Irvine and Selexis will jointly present the results on Tuesday, October 13, 2009 at 11:45 AM at the BioProcess International Conference 2009 being held in Raleigh, North Carolina. Results of the program demonstrate the ability to produce gram quantities of therapeutic antibodies in 16 weeks using a CHO platform designed specifically for large scale cGMP manufacturing.

"By combining the world class media development capabilities found at Irvine Scientific with the speed and performance of the Selexis SURE Cell Line Development(TM) program a very powerful CHO based production platform has been developed," said Dr. Igor Fisch, CEO and co-founder of Selexis SA. "This platform can be implemented for the production large qualities of antibody or recombinant protein useful for preclinical and clinical development purposes, which is beneficial to both our licensees and service clients."

"Our scientists have been able to quickly develop and apply an advanced media program to support the speed and performance of the Selexis system in achieving gram per liter productivities in matter of weeks," said Makoto Shintani, Chief Executive Officer. "It is clear that this program can provide significant benefits to biotech companies in need of large quantities of antibodies or proteins quickly."

About Selexis:

Selexis is a privately held Swiss biotechnology company dedicated to the development of innovative technologies and expert services that enable significant improvements in the time, effort, and costs required to develop and maintain high-performance mammalian cell lines used in the expression of pharmaceutically relevant proteins (i.e. targets, MAbs, rProteins). The company's core intellectual property portfolio is based on the discovery and application of novel DNA based elements that control the dynamic organization of chromatin within all mammalian cells - Selexis Genetic Elements(TM). Selexis has further developed platforms, to include: Selexis SUREtech Vectors(TM), Selexis SUREfection(TM) Selexis SURE Cell Line Development(TM) and Selexis INTEGRA-D2M(TM).

About Irvine Scientific:

Irvine Scientific, a subsidiary of Japan Energy Corporation, is a worldwide leader in the design, manufacture and distribution of medical devices including Industrial Cell Culture, Cytogenetic, and Assisted Reproductive Technology (ART) products. Irvine Scientific is a large scale producer of advanced and quality cell culture media for the industrial bioprocess and diagnostic markets. The company has extensive experience in the design of culture media leading to significant improvement in biopharmaceutical production yield. The company also manufactures media for medical and stem cell applications.

Irvine Scientific's worldwide distribution channels deliver products to large scale biopharmaceutical industry and to the research and laboratory communities.

    For more information contact:

    Irvine Scientific
    Phone: +949-261-7800

    Phone: +41 (0)22 308 93 60

SOURCE Irvine Scientific Inc.

SOURCE Irvine Scientific Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Seasoned Dermatologist Nissan Pilest of Irvine, CA, Joins SDS Clinical Trials as Clinical Investigator for Dermatology Division
2. Irvine Scientific Announced Today a New Distribution Partnership With Prodimed
3. Allied Minds Establishes New Company to Commercialize Novel UC Irvine Tinnitus Therapy
4. Irvine Scientific Launches IS CHO-CD XP(TM)
5. Irvine Dermatologist Begins In-office Clinical Studies -- Nissan Pilest, MD Combines Multi-Use Botox in Laser Resurfacing Clinical Studies
6. Families of Spinal Muscular Atrophy; University of California, Irvine Stem Cell Scientist; and California Stem Cell Announce Collaboration for Safety Studies for Stem Cell Therapy in Spinal Muscular Atrophy
7. BioMed Realty Trust Appoints Executive Officer of the Irvine Company to Its Board
8. Edwards Lifesciences Grants UC Irvine $5 Million to Establish the Edwards Lifesciences Center for Advanced Cardiovascular Technology
9. Nanogea Announces New Scientific Advisory Board Members
10. Boston Scientific Announces Exclusive Sponsorship and First Enrollments of MADIT-RIT Clinical Trial
11. Global Public Health the Focus of Scientific Conference
Post Your Comments:
(Date:10/9/2015)... HERSHEY, Pa. and ROCKVILLE, ... Therapeutics, Inc. ("ITI"), a privately-held biotechnology company developing ... today announced that it has entered into an ... on LAMP-vax products for the treatment or prevention ... Upon execution of the agreement, Immunomic Therapeutics will ...
(Date:10/9/2015)... ... October 09, 2015 , ... ... the current methods of separating those cells from their surroundings for research, diagnostics, ... the cells. , To address this, Ann Arbor-based startup Akadeum Life Sciences ...
(Date:10/8/2015)... 8, 2015   Intrexon Corporation (NYSE: ... the appointment of Joseph L. Vaillancourt as ... Nir Nimrodi who continues in his role as ... endeavors to generate sustainable, biologically based solutions to environmental ... he held a variety of key roles including, Vice ...
(Date:10/8/2015)...  ATCC, the premier global biological materials resource and ... by The Michael J. Fox Foundation for Parkinson,s Research ... and biotechnology organizations committed to speed a cure for ... , and more than 5 million worldwide, have ... , and more than 5 million worldwide, have ...
Breaking Biology Technology:
... SANFORD, Maine, Jan. 31, 2012  Maine Manufacturing, LLC announced ... GE Healthcare granting Maine Manufacturing the exclusive right to ... line.  Maine Manufacturing, which has been manufacturing the FAST ... FAST Slides and accessories including FAST Quant, direct to ...
... Jan. 26, 2012 Life Technologies Corporation (NASDAQ: ... company,s presentations at the following upcoming investment conferences in ... Life Technologies will present at the Leerink Swann 2012 ... a.m. ET. Life Technologies will also present ...
... 2012  ZyGEM Corp. Ltd., a developer and marketer of ... nucleic acids, today announced that it has signed an ... DNA and RNA extraction kits.  SDL was established by ... as part of the Saudi Arabian government,s drive to ...
Cached Biology Technology:
(Date:10/8/2015)... 8, 2015 NXT-ID, Inc. ... a biometric authentication company focused on the growing ... smart wallet announces that revenues for the three ... compared with $113,00 for the three months ended ... ended September 30, 2015 were approximately $520,000. ...
(Date:10/6/2015)... LAKE CITY , Oct. 6, 2015 ... company, announced today that it has signed a contract ... monitoring services across the full range of sentences under ... Group,s President of the Americas. "This contract with the ... region of the US and advances our position as ...
(Date:10/2/2015)... DUBLIN , Oct. 02 2015 ... addition of the "Enforcing the Law Using ... ) has announced the addition of ... report to their offering. --> Research ... addition of the "Enforcing the Law Using ...
Breaking Biology News(10 mins):
... that ever walked the earthIndricotherium transouralicum, a hornless ... stood about eighteen feet high at the shoulderlived ... largest mammal that ever walked the earth Indricotherium ... approximately seventeen tons and stood about eighteen feet ...
... and other pathogens result in global crop losses of over ... Institution,s Department of Plant Biology developed a novel trick for ... organism. They discovered a novel family of pores that transport ... pores to access the plant sugar for food. The first ...
... , In the scorching summer heat of the Chihuahuan ... 97F (36C) while at the surface of the soil ... extreme temperatures, plants must utilize creative methods to not ... lethal conditions. This new work by Dr. Gretchen ...
Cached Biology News:
... The pPIC9K and pPIC3.5K vectors carry the ... Geneticin Reagent in Pichia. Spontaneous generation of ... resistance to increased levels of Geneticin Reagent. ... and screened for their level of resistance ...
... Clone/PAD: ZMD.478. Immunogen: Synthetic ... of the humanmouse and bovine Math-2. ... protein. Reactivity: Human Rat (positive ... rat B28 cell lysates and rat ...
solute carrier family 25, member 13 (citrin)...
Biology Products: